This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sonomed Escalon™ Announces Release Of AXIS™ IPad App

WAYNE, Pa., Feb. 23, 2012 /PRNewswire/ -- Escalon Medical Corp.'s (Nasdaq Market: ESMC) subsidiary,  Sonomed Escalon™ announced the release of its new iPad App for the AXIS™ Image Management System at the recent World Ophthalmology Congress held February 16-20 in Abu Dhabi, UAE.

Matthew Carnevale, Chief Technical Officer, stated that "the AXIS iPad App is an industry first in ophthalmic diagnostic imaging management, and provides an entirely new level of flexibility and power.  A clinician can now view all of their ophthalmic diagnostic images from anywhere at any time on their iPad, including slice-by-slice review of OCT images, fundus images, ultrasound, visual fields and more."  The AXIS iPad App was first displayed pre-release at the American Academy of Ophthalmology meeting held October 22-25 2011 in Orlando FL.  In addition, AXIS and the iPad App were on display in the Heidelberg Engineering booth to showcase the combination of AXIS and the Heidelberg Spectralis OCT/SLO system.  Mr. Carnevale continued, "The response to the powerful combination of the AXIS iPad App and the Heidelberg Spectralis was overwhelming."

AXIS is a web-based image management system accessible from any standard Internet browser that manages all images from any ophthalmic diagnostic device within a single database. The AXIS iPad App seamlessly integrates with AXIS to provide image review capabilities within an efficient and portable platform.

The AXIS iPad App is now available in the Apple App Store. Sonomed Escalon™ is the new combined ophthalmic products brand of Escalon Medical Corp.

Founded in 1987, the Company ( www.escalonmed.com) develops, markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products. Drew Scientific, which operates as a separate business unit, provides instrumentation and consumables for the diagnosis and monitoring of medical disorders in the areas of diabetes, cardiovascular diseases and hematology, as well as veterinary hematology and blood chemistry. The Company seeks to utilize strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of the Company 's distribution capabilities, although such partnerships or acquisitions may not occur. The Company has headquarters in Wayne, Pennsylvania and operations in Long Island, New York, New Berlin, Wisconsin, Lawrence, Massachusetts, Dallas, Texas, Waterbury, Connecticut, Miami, Florida and Barrow-in-Furness, U.K.

Note:  This press release contains statements that are considered forward-looking under the Private Securities Litigation Reform Act of 1995, including statements about the Company's future prospects. These statements are based on the Company's current expectations and are subject to a number of uncertainties and risks, and actual results may differ materially. The uncertainties and risks include whether the Company is able to:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs